Search Browse Earnings

VACCINEX, INC.

OTC:VCNX

Pharmaceutical Preparations·ROCHESTER, NY

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

VACCINEX, INC. — SlamSEC

Revenue

$570,000

+107.3% YoY

FY 2024

Adj. EBITDA

-$22.7M

-3975.8% margin

FY 2024

Net Income

-$20.3M

-3552.8% margin

FY 2024

EPS (Diluted)

-$43.68

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$1.5M

FY 2024

Total Debt

$26,000

FY 2024

Net Cash

$1.5M

FY 2024

Enterprise Value

—

Debt / EBITDA

0.1x

FY 2024

EV / EBITDA

—

Employees

—

CEO

Zauderer Maurice